Bank of New York Mellon
CBST

Bank of New York Mellon’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bank of New York Mellon’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-722,031
Closed -$72.7M – 4339
2014
Q4 		$72.7M Sell
722,031
-3,605,622
-83% -$280M 0.02% 712
2014
Q3 		$287M Buy
4,327,653
+611,217
+16% +$40.1M 0.08% 274
2014
Q2 		$259M Buy
3,716,436
+613,315
+20% +$41.7M 0.07% 293
2014
Q1 		$227M Buy
3,103,121
+143,864
+5% +$10.7M 0.06% 326
2013
Q4 		$204M Sell
2,959,257
-518,242
-15% -$33.5M 0.06% 342
2013
Q3 		$221M Buy
3,477,499
+101,809
+3% +$6.15M 0.07% 311
2013
Q2 		$163M Buy
+3,375,690
New +$166M 0.05% 366

Bank of New York Mellon's CBST Position: Q1 2015 in Review

Bank of New York Mellon sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 722,031 shares — an estimated $72.7M sold.

Bank of New York Mellon first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $287M in Q3 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Bank of New York Mellon reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 722,031 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $72.7M.
  • Bank of New York Mellon first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of New York Mellon's CUBIST PHARMACEUTICALS INC position peaked at $287M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.